About Standard BioTools Inc.
Standard BioTools Inc., previously known as Fluidigm Corp., is an American life science tools company that offers analytical mass cytometry systems for flow cytometry and tissue imaging, along with associated assays and reagents, as well as an automated genomic analysis instrument and a variety of microfluidic arrays, or integrated fluidic circuits, and consumables with fully kitted reagents. Custom assays and services are available with all systems and applications.
2BB score and signals
Standard BioTools Inc.’s current 2BB score is 45 out of 100, built from the signal categories below.
| Signal | Score | Reading |
|---|
| Activity | 51 | Moderate |
| Momentum | 64 | Improving |
| Financial strength | 24 | Weak |
| Quality | 100 | Very Strong |
| Risk | 42 | Moderate |
Company facts
| Headquarters | Boston, Massachusetts, United States |
| Founded | 1999 |
| Employees | 387 |
| 52-week range | $0.70 – $1.72 |
Recent earnings
| Report date | EPS actual | EPS estimate | Revenue actual | Revenue estimate |
|---|
| 2026-11-02 | — | -0.0202 | — | $18.60M |
| 2026-08-05 | — | -0.0131 | — | $21.01M |
| 2026-05-05 | 0.33 | -0.0606 | $21.15M | $17.99M |
| 2026-02-24 | 0.05 | -0.0707 | $23.80M | $18.69M |
Related companies
